** Shares of Australia's Proteomics International Laboratories PIQ.AX rise as much as 7.6% to A$0.570, their highest level since late-February

** Medical technology firm secures U.S. patent for PromarkerEso diagnostic testfor early diagnosis of esophageal cancer

** Stock is down 28.8% YTD, including the session's moves

(Reporting by Anjali Singh in Bengaluru)

((anjali.singh2@thomsonreuters.com; ))